Biogen ROE Ratio 2011-2026 | BIIB

Annual ROE Ratio Biogen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
7.08	9.76	7.85	22.76	14.28	37.44	44.14	34.0	20.15	30.53	37.84	27.14	21.6	19.82	19.21

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
44.14	7.08	23.57

Quarterly ROE Ratio Biogen

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
11.06	10.05	8.16	9.88	9.02	15.32	24.68	29.51	20.51	23.54	17.68	12.93	15.08	18.42	21.95	32.19	37.39	44.83	49.86	46.65	44.13	40.6	40.09	35.54	33.98	24.36	23.0	23.2	20.13	27.84	26.62	28.43	30.5	34.03	35.82	37.07	37.84	37.14	34.77	31.49	27.15	24.28	22.01	21.09	21.6	20.49	20.56	20.43	19.82	20.3	20.05	18.98	19.21	5.48	4.48	4.58

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
49.86	4.48	24.93

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Amarin Corporation plc AMRN	-10.71	$ 14.75	-0.74 %	$ 6.01 B	Irlanda
Acer Therapeutics ACER	156.54	-	2.71 %	$ 14 M	USA
Acasti Pharma ACST	-14.36	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
Anavex Life Sciences Corp. AVXL	-48.89	$ 4.12	5.07 %	$ 351 M	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Adagene ADAG	-66.16	$ 3.17	11.23 %	$ 178 M	China
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Aptorum Group Limited APM	-20.19	$ 0.77	-10.2 %	$ 4.2 M	China
AlloVir ALVR	-51.87	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Ampio Pharmaceuticals AMPE	-256.9	-	-11.43 %	$ 502 K	USA
Alterity Therapeutics Limited ATHE	-36.22	$ 3.48	-0.83 %	$ 8.37 B	Australia
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	-21.9	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Aptose Biosciences APTO	559.76	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Athira Pharma ATHA	-216.19	-	-	$ 269 M	USA
Aeglea BioTherapeutics AGLE	-40.17	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	-19.38	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Allena Pharmaceuticals ALNA	-257.91	-	3.16 %	$ 1.9 M	USA
Ascendis Pharma A/S ASND	-43.41	$ 215.19	-1.33 %	$ 5 B	Danmark
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	-91.56	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	125.33	-	17.91 %	$ 11.1 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Brickell Biotech BBI	-57.34	-	-5.38 %	$ 6.06 M	USA
AgeX Therapeutics AGE	-270.67	-	-10.17 %	$ 12.2 K	USA
Bristol-Myers Squibb Company BMY	38.19	$ 60.64	1.33 %	$ 123 B	USA
Athersys ATHX	-531.22	-	3.77 %	$ 22.4 M	USA
BioNTech SE BNTX	1.11	$ 106.73	0.92 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	-418.16	-	-52.27 %	$ 4.45 M	USA
BeiGene, Ltd. BGNE	-19.35	-	0.49 %	$ 251 B	Cayman-islands
Autolus Therapeutics plc AUTL	-51.64	$ 1.4	1.59 %	$ 357 M	Britain
Burford Capital Limited BUR	10.1	$ 9.35	0.54 %	$ 1.51 B	Britain
Amneal Pharmaceuticals AMRX	67.61	$ 14.93	2.05 %	$ 4.61 B	USA
AIkido Pharma AIKI	-36.89	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	12.83	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	-32.19	-	-	$ 2.17 B	USA